Australia's largest stock trading and investment forum Australia's #1 stock forum

SE1

Click for more information

0.00%

0.2¢ sensera limited

Ann: Customer Update, page-64

First 64 Last

Share
Profile

Follow
Caerus888

40 Posts.

12

19/08/21

11:16

Post #: 55409703
Share

Originally posted by dpdebrec: ↑

From Sensera's May 2021 Investor Update:

"The reliance on Abiomed is being reduced as the company now
has one additional, and potentially two additional, customers
moving into volume production. "

If BOTH Nanodx & Nova BioMedical move into volume production over the remainder of the Sep 21 quarter and the Dec '21 quarter, we could feasibly be looking at Revenue for C2022 in excess of USD 20 million !!

QUESTION for HC Posters:
At what stage does Sensera become a takeover target & at what price would TAKEOVER be successful.

In my opinion, once EITHER NanoDx or Nova BioMedical ramp up into volume production, the GAME is on.
Any takeover would be unsuccessful at less than USD 100 million which equates to approx A$ 0.35 per share.

I think that if NanoDx get EUA before end of calendar year, my above estimate of Revenue for C2022 of USD 20 mill will be wildly under the mark.
Look at the daily Covid figures around the world !!

At these levels Sensera is a NO BRAINER !

Expand

No brainer @ 3.1 / 3.2. Hence why I have been purchasing more to average down.

SE1 Price at posting: 3.2¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 9 more messages in this thread...

First 64 Last

Add SE1 (ASX) to my watchlist